Perinatal Depression and Adverse Childhood Experiences: Prevention Trial
Prevention of Perinatal Depression in Birthing People With a History of Adverse Childhood Experiences: A Type 2 Effectiveness Implementation Trial
Northwestern University
76 participants
Jul 20, 2023
INTERVENTIONAL
Conditions
Summary
The goal of this clinical trial is to evaluate the impact of ROSE in individuals with adverse childhood experiences. The main question it aims to answer is, compared to enhanced treatment as usual, does the delivery of ROSE within a collaborative care model improve depressive symptom trajectories and prevent the development of perinatal depression. Participants will be randomized to either enhanced treatment as usual or the ROSE intervention, delivered by a care manager within a perinatal collaborative care program. They will complete self-reported surveys of their depression symptoms every 4 weeks to inform their symptom trajectories. They will also complete clinical interviews to establish any incident diagnoses of a major depressive episode.
Eligibility
Inclusion Criteria7
- Age ≥ 18 years
- At least one prenatal visit at Northwestern Medicine
- Less than 24 weeks gestation
- Non-anomalous pregnancy
- English- or Spanish- speaking
- ACE score ≥ 2
- Singleton gestation
Exclusion Criteria4
- Intent to delivery outside of Prentice Women's Hospital
- Active major depressive episode
- Active substance use disorder
- Participation in a study with a competing intervention or outcome
Interventions
A 5-part interpersonal therapy based intervention
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05795114